Caitlin Kindberg, patient advocate in Nashville, Tennessee, discusses her lived experience as an individual with idiopathic hypersomnia, and how the sleep disorder impacts her day-to-day life.
It's important that patients with idiopathic hypersomnia (IH) continue to advocate for themselves and push for better treatment despite challenges, Caitlin Kindberg, patient advocate in Nashville, Tennessee, explained to The American Journal of Managed Care® (AJMC®) at the SLEEP 2024 Annual Meeting.
Transcript
How did you learn you had idiopathic hypersomnia?
I was always a pretty sleepy kid. I thought it was more of a personality trait of mine, and I really didn't understand that what I was experiencing was abnormal. So, after many, many years, I actually met a stranger at a friend's birthday party and started explaining some of my symptoms with him, and he was a respiratory therapist. So, he was the one who actually recommended that I see a sleep specialist. At my first appointment, I really knew that I was in the right place to get a diagnosis just based on the questions that my provider was asking me. And after a 24-hour sleep study, the results of that led to my diagnosis of idiopathic hypersomnia at 25 years old.
Can you share your overall patient experience as someone living with idiopathic hypersomnia?
As someone living with idiopathic hypersomnia, my patient experience has been pretty frustrating. After receiving the diagnosis, I was relieved because now I had a name for my symptoms, but the fact that IH is rare and a chronic disease makes it pretty challenging. So, finding a sleep specialist that knew what IH was and how to properly treat it took a few years.
How does idiopathic hypersomnia affect mental health and emotional well-being?
Idiopathic hypersomnia affects pretty much every aspect of one's life, but I would say especially your mental and emotional well-being. My quality of sleep directly impacts my mood, and I never get quality sleep. So, this can sometimes lead to me having a short fuse, being easily irritated, and snapping over something that's pretty minor, or I just feel extremely sad or anxious for seemingly no reason. I feel like again, it's kind of like part of my personality traits. People describe me as overly sensitive and emotional, but I think it's primarily due to my lack of quality sleep because I noticed on days where my IH symptoms are worse, so is my mood.
The Push for Fair Pricing and Reform in Pharmacy Benefit Management
April 3rd 2025Amid growing legislative pressures and industry debates, pharmacy benefit managers (PBMs) are exploring new strategies to enhance transparency, reduce patient costs, and navigate the evolving healthcare landscape.
Read More
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Using AI-Driven Strategies to Optimize Specialty Drug Costs, Manage Polypharmacy
April 2nd 2025As health care costs continue to rise, artificial intelligence (AI)-driven solutions are emerging as a powerful tool for managing specialty drug spending and polypharmacy risks, as showcased in recent research presented at the Academy of Managed Care Pharmacy 2025 conference.
Read More
How Recent Federal Policy Changes Are Shaping Managed Care Pharmacy
April 2nd 2025Federal legislative and regulatory changes are reshaping pharmacy practice, with key challenges in government funding, pharmacy benefit manager reform, and health care policy shifts—topics explored by experts at the Academy of Managed Care Pharmacy's annual meeting.
Read More
The IRA’s Unintended Consequences for Drug Pricing and Coverage
April 2nd 2025The Inflation Reduction Act (IRA) may be restricting Medicare Part D formularies, increasing patient costs, and stifling pharmaceutical innovation, experts warned at the Academy of Managed Care Pharmacy 2025 annual meeting.
Read More
The Push for Fair Pricing and Reform in Pharmacy Benefit Management
April 3rd 2025Amid growing legislative pressures and industry debates, pharmacy benefit managers (PBMs) are exploring new strategies to enhance transparency, reduce patient costs, and navigate the evolving healthcare landscape.
Read More
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Using AI-Driven Strategies to Optimize Specialty Drug Costs, Manage Polypharmacy
April 2nd 2025As health care costs continue to rise, artificial intelligence (AI)-driven solutions are emerging as a powerful tool for managing specialty drug spending and polypharmacy risks, as showcased in recent research presented at the Academy of Managed Care Pharmacy 2025 conference.
Read More
How Recent Federal Policy Changes Are Shaping Managed Care Pharmacy
April 2nd 2025Federal legislative and regulatory changes are reshaping pharmacy practice, with key challenges in government funding, pharmacy benefit manager reform, and health care policy shifts—topics explored by experts at the Academy of Managed Care Pharmacy's annual meeting.
Read More
The IRA’s Unintended Consequences for Drug Pricing and Coverage
April 2nd 2025The Inflation Reduction Act (IRA) may be restricting Medicare Part D formularies, increasing patient costs, and stifling pharmaceutical innovation, experts warned at the Academy of Managed Care Pharmacy 2025 annual meeting.
Read More
2 Commerce Drive
Cranbury, NJ 08512